A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology Study (NCT#01281852)

P. H. Thaker, R. Salani, W. E. Brady, H. A. Lankes, D. E. Cohn, D. G. Mutch, R. S. Mannel, K. M. Bell-McGuinn, P. A. Di Silvestro, D. Jelovac, J. S. Carter, W. Duan, K. E. Resnick, D. S. Dizon, C. Aghajanian, P. M. Fracasso

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology Study (NCT#01281852)'. Together they form a unique fingerprint.

Medicine & Life Sciences